Shenkman Capital Management »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Shenkman Capital Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Shenkman Capital Management from 13F filings

Historical chart of Shenkman Capital Management investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Shenkman Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Shenkman Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.2B 8.7M 1054.01

More positions owned by Shenkman Capital Management

Ishares Tr Broad Usd High (USHY)
Spdr Series Trust State Street Spd (SJNK)
Etsy Note 0.250% 6/1 (Principal)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Akamai Technologies Note 1.125% 2/1 (Principal)
Strategy Note 12/0 (Principal)
Rivian Automotive Note 3.625%10/1 (Principal)
Cms Energy Corp Note 3.375% 5/0 (Principal)
Super Micro Computer Note 3.500% 3/0 (Principal)
On Semiconductor Corp Note 0.500% 3/0 (Principal)
Varonis Sys Note 1.000% 9/1 (Principal)
Dropbox Note 3/0 (Principal)
Global Pmts Note 1.500% 3/0 (Principal)
Parsons Corp Del Note 2.625% 3/0 (Principal)
Blackline Note 1.000% 6/0 (Principal)

View all positions for Shenkman Capital Management

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Context Capital Management
Bnp Paribas Arbitrage, Snc
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management
SSI Investment Management
Ing Investment Management
UBS Group

View all funds holding Arrowhead Pharmaceuticals In Note 1/1